DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

50.65 0.11 (0.22%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMY $50.65 0.22%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.67
Previous Close $50.54
Daily Range $50.30 - $50.68
52-Week Range $41.32 - $57.49
Market Cap $84.0B
P/E Ratio 31.46
Dividend (Yield) $1.44 (2.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,020,592
Average Daily Volume 5,717,264
Current FY EPS $1.77





Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary Rss Feed

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned - Analyst Blog

Bristol-Myers Squibb Gets European Approval For HCV Drug Daklinza

Bristol-Myers: Absolute Valuation Model versus Relative Valuation Model

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog

Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences

European approval of Bristol-Myers Squibb's Daklinza could derail sales of Johnson & Johnson's Olysio, but is unlikely to unseat Gilead's Sovaldi.

Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

Will This Coverage Initiation Affect Bristol-Myers Squibb (BMY) Stock Today?

3 Reasons Pfizer Inc.'s Stock Could Fall

Despite rumors about mergers and acquisitions, these three catalysts could wind up pressuring Pfizer's stock and ultimately pushing it lower.

Analysts' Actions: Akamai, Bristol-Myers, Eli Lilly, Merck, Pfizer

See More BMY News...

BMY's Top Competitors

BMY $50.65 (0.22%)
Current stock: BMY
JNJ $103.73 (0.76%)
Current stock: JNJ
NVS $89.84 (0.12%)
Current stock: NVS
RHHBY $36.51 (-0.14%)
Current stock: RHHBY